Revisiting the Dexcom G6, now that #WeAreNotWaiting and have adapted to it…
Back at the end of March, when Dexcom launched the G6, I questioned how this might affect those using WeAreNotWaiting open source Diabetes technology. It […]
Blog Posts
Trying #Fiasp again, six months later…
After six months of leaving Fiasp on the shelf, and occasionally using it as an adjunct injection when fast carbs were consumed (where it still […]
Yet another new CGM system – with a MARD of 8.67%… Welcome the POCTech CT-100
***Updated following clarification from the UK Distributor*** Whilst I recently tested and reported back on the Medtrum A6 CGM system, it’s not the only newcomer […]
A month with Medtrum’s A6 CGM
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
Medtrum A6 CGM – A week (or two) in the life
After the initial couple of days with the Medtrum, and the data that was produced, I thought it would be a good idea to provide […]
The Medtrum A6 CGM. Initial impressions on performance…
Following the earlier article on what you get when you buy a Medtrum A6 CGM, let me precipitate this piece by mentioning that it contains […]
Disruption in CGM land… Can Medtrum take Dexcom’s crown?
Back in August 2016, I met Medtrum at a JDRF Discovery day. They seemed to be offering a new set of options in the CGM […]
Dexcom’s G6 has arrived. How might it work for #WeAreNotWaiting users?
So then. It’s official. After three long years, the Dexcom G6, with its new insertion device has been released. Complete with lower profile, calibration free […]
Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world
If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]
Rise of the Machines – Technology and “patient-driven” innovation in the treatment of diabetes #T1DRoM
On Saturday, if you didn’t know already, we ran a first for the UK. A day’s conference focusing on Diabetes Technology, and majoring on “Patient […]